a public good project by the
Synthesis
Company
of California

© 2026

Hannah Yang | doi.page

0 works0 citations0 h-index

Hannah Yang

Central Michigan University(US)University of Calgary(CA)CHA University Bundang Medical Center(KR)CHA University(KR)Hanyang University(KR)

Publications by Year

Research Areas

Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, Cancer-related molecular mechanisms research, Cancer Risks and Factors, Cancer Genomics and Diagnostics

Most-Cited Works

→ Type I and II Endometrial Cancers: Have They Different Risk Factors?(2013)816 cited
→ Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity(2020)620 cited
→ Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium(2016)506 cited
→ Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study(2013)424 cited
→ A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2(2009)309 cited
→ STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade(2019)297 cited

→ Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium(2013)

228 cited

→ Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer(2013)169 cited

→ Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium(2015)155 cited

→ Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade(2018)154 cited